Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Padiporn Limumpornpetch"'
Autor:
Maria Fleseriu, Chioma Iweha, Luiz Salgado, Tania Longo Mazzuco, Federico Campigotto, Ricardo Maamari, Padiporn Limumpornpetch
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Introduction: The efficacy and safety of subcutaneous (sc) pasireotide have been evaluated in a Phase III trial. Here, we report safety and efficacy results from a multinational, expanded-access study of pasireotide sc in patients with Cushing's dise
Externí odkaz:
https://doaj.org/article/398a249f1b47463494ec5336156e3976
Autor:
Padiporn Limumpornpetch, Ann W Morgan, Ana Tiganescu, Paul D Baxter, Victoria Nyawira Nyaga, Mar Pujades-Rodriguez, Paul M Stewart
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(8)
Objective We aimed to perform a systematic review and meta-analysis of all-cause and cause-specific mortality of patients with benign endogenous Cushing syndrome (CS). Methods The protocol was registered in PROSPERO (CRD42017067530). PubMed, EMBASE,
Publikováno v:
Polish Journal of Radiology. 11/4/2019, Vol. 84, pe136-e141. 6p.
Publikováno v:
Polish Journal of Radiology
Purpose: To report the success rate of adrenal venous sampling (AVS) and identify the predictors for procedural success. Material and methods: Sixty-four patients (18 men and 46 women) with a mean ± SD age of 50 ± 11.8 years (range 28-69 years) dia
Autor:
Mark Sherlock, Andrew Scarsbrook, Afroze Abbas, Sheila Fraser, Padiporn Limumpornpetch, Rosemary Dineen, Paul M Stewart
Publikováno v:
Endocrine Reviews
An adrenal incidentaloma is now established as a common endocrine diagnosis that requires a multidisciplinary approach for effective management. The majority of patients can be reassured and discharged, but a personalized approach based upon image an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edb315a5ec8ebee33aa7decf28d12f3
https://eprints.whiterose.ac.uk/159639/1/bnaa008.pdf
https://eprints.whiterose.ac.uk/159639/1/bnaa008.pdf
Autor:
Ana Tiganescu, Mar Pujades-Rodriguez, Padiporn Limumpornpetch, Paul M. Stewart, Ann W. Morgan
Publikováno v:
Journal of the Endocrine Society
Chronic oral glucocorticoid (GC) exposure from therapeutic anti-inflammatory or immunosuppressive use is the most common cause of Cushing’s syndrome (CS). Previous studies of glucocorticoid therapy and mortality have produced inconsistent results a
Autor:
Ana Tiganescu, Mar Pujades Rodriguez, Victoria Nyawira Nyaga, Padiporn Limumpornpetch, Paul M. Stewart, Ann W. Morgan, Paul D. Baxter
Publikováno v:
Journal of the Endocrine Society
Background: Glucocorticoids (GCs) are widely used as therapeutic agents with prevalence 0.9–3.7%, but they are associated with significant side effects. Understanding of mortality ratios and causes of death from GC use is poorly appreciated and lik
Autor:
Padiporn Limumpornpetch, Paul D. Baxter, Victoria Nyawira Nyaga, Ana Tiganescu, Mar Pujades-Rodriguez, Paul M. Stewart, Ann W. Morgan
Publikováno v:
Journal of the Endocrine Society
Background: Endogenous Cushing’s syndrome (CS) refers to an inappropriate hypercortisolism usually caused by either Cushing’s disease (CD) or adrenal CS (ACS). CS results in significant morbidity and excess mortality if untreated. Even in treated
Autor:
Heather Patino, Chioma Iweha, Padiporn Limumpornpetch, Ricardo Maamari, Federico Campigotto, Luiz Roberto Salgado, Maria Fleseriu, Tania Longo Mazzuco
Publikováno v:
Endocrine Abstracts.